Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Meningococcal Vaccines in Adults - An Exploratory, Open-label, Immunogenicity Study of a Licensed Meningococcal Capsular Group B Vaccine (4CMenB, Bexsero®) in Adults

NCT02398396 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT02398396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02398396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Meningococcal Vaccines in Adults - An Exploratory, Open-label, Immunogenicity Study of a Licensed Meningococcal Capsular Group B Vaccine (4CMenB, Bexsero®) in Adults
Lead sponsor
University of Oxford
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
June 13, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

factor h-binding protein, neisseria meningitidi, meningococcal infections, meningococcal vaccines, neisseria meningitidis